Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

14-year study finds that quitting smoking adds years to life

15.02.2005


Participants who quit had a 46% lower death rate



In a new study of 5,887 middle-aged smokers with mild lung disease, those who were randomly assigned to a quit-smoking program had a lower death rate than those assigned to usual care, even though only 21.7 percent of them actually quit smoking.
The annual death rates were 8.8 per 1000 participants in the quit-smoking program and 10.4 per 1000 in the usual care group. The annual death rates for those who actually quit was even more positive: 6.0 per 1000 patients compared with 11.0 per 1000 in those who did not quit smoking. Overall, the death rate of those in both groups who were able to quit smoking was 46 percent lower than those who did not quit.

The study, "The Effects of a Smoking Cessation Intervention on 14.5-year Morality," is the first experimental study to show that stopping smoking adds years to life. It is published in the Feb. 15, 2005, issue of Annals of Internal Medicine. The findings were based on data from the Lung Health Study. Randomized trials like the Lung Health Study are widely regarded as the gold standard for proof among clinical studies. "We know that people who smoke should quit smoking," said one of the study authors, John E. Connett, PhD, professor of biostatistics of the University of Minnesota School of Public Health. "This study showed that with very simple lung function tests -- spirometry -- we can find people who can benefit the most from an intensive quit-smoking program," Connet said. "And it not only made them healthier and feel better, it caused substantial reductions in death rate."



The participants in the study all had mild lung disease, which itself increases risk for more serious lung disease down the road. In an editorial, "Smoking Kills, Experimental Proof from the Lung Health Study," Jonathan M. Samet, MD, MS, of the Johns Hopkins Bloomberg School of Public Health, says that the importance of the new findings is that the study was randomized and was large enough and long enough to truly test whether smoking cessation reduces all-cause mortality. Previous studies linking smoking to death from specific diseases, such as lung cancer and heart disease, were based on observation rather than on experiment. These new findings "prove that smoking causes increased risk for death in smokers," Dr. Samet said in the editorial. "No one can make a serious claim to the contrary in light of this randomized trial evidence."

A surprising finding, according to Dr. Connett, was that the reduction in death rate was more significant in younger people, 35 to 45, than older people. "Current guidelines suggest that smokers over age 45 should be screened, but our study found that younger people have more to gain from being screened than older people," Connett said. "Young people who are found to have abnormal lung function should be put into an aggressive quit-smoking program."

Dr. Connett commented on the unusual study finding that even those who did not quit smoking completely had lower death rates than the people who continued to smoke throughout. "One might have thought that this program was not working, because by most standards, only 20 percent or so of the people who were enrolled in it quit smoking continuously," Connett said. "People quit, restarted, and quit again. However, quitting had such a statistically large impact on the overall population that even though many people quit and started smoking again, as long as they were smoke-free for periods of time, they had better outcomes than those who continued to smoke."

Susan Anderson | EurekAlert!
Further information:
http://www.acponline.org

More articles from Studies and Analyses:

nachricht Do microplastics harbour additional risks by colonization with harmful bacteria?
05.04.2018 | Leibniz-Institut für Ostseeforschung Warnemünde

nachricht Rutgers-led innovation could spur faster, cheaper, nano-based manufacturing
14.02.2018 | Rutgers University

All articles from Studies and Analyses >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Spider silk key to new bone-fixing composite

University of Connecticut researchers have created a biodegradable composite made of silk fibers that can be used to repair broken load-bearing bones without the complications sometimes presented by other materials.

Repairing major load-bearing bones such as those in the leg can be a long and uncomfortable process.

Im Focus: Writing and deleting magnets with lasers

Study published in the journal ACS Applied Materials & Interfaces is the outcome of an international effort that included teams from Dresden and Berlin in Germany, and the US.

Scientists at the Helmholtz-Zentrum Dresden-Rossendorf (HZDR) together with colleagues from the Helmholtz-Zentrum Berlin (HZB) and the University of Virginia...

Im Focus: Gamma-ray flashes from plasma filaments

Novel highly efficient and brilliant gamma-ray source: Based on model calculations, physicists of the Max PIanck Institute for Nuclear Physics in Heidelberg propose a novel method for an efficient high-brilliance gamma-ray source. A giant collimated gamma-ray pulse is generated from the interaction of a dense ultra-relativistic electron beam with a thin solid conductor. Energetic gamma-rays are copiously produced as the electron beam splits into filaments while propagating across the conductor. The resulting gamma-ray energy and flux enable novel experiments in nuclear and fundamental physics.

The typical wavelength of light interacting with an object of the microcosm scales with the size of this object. For atoms, this ranges from visible light to...

Im Focus: Basel researchers succeed in cultivating cartilage from stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Certain mesenchymal stem/stromal cells from the bone marrow of adults are considered extremely promising for skeletal tissue regeneration. These adult stem...

Im Focus: Like a wedge in a hinge

Researchers lay groundwork to tailor drugs for new targets in cancer therapy

In the fight against cancer, scientists are developing new drugs to hit tumor cells at so far unused weak points. Such a “sore spot” is the protein complex...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

Invitation to the upcoming "Current Topics in Bioinformatics: Big Data in Genomics and Medicine"

13.04.2018 | Event News

Unique scope of UV LED technologies and applications presented in Berlin: ICULTA-2018

12.04.2018 | Event News

IWOLIA: A conference bringing together German Industrie 4.0 and French Industrie du Futur

09.04.2018 | Event News

 
Latest News

Magnetic nano-imaging on a table top

20.04.2018 | Physics and Astronomy

Start of work for the world's largest electric truck

20.04.2018 | Interdisciplinary Research

Atoms may hum a tune from grand cosmic symphony

20.04.2018 | Physics and Astronomy

VideoLinks
Science & Research
Overview of more VideoLinks >>>